BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 27659679)

  • 21. Mechanisms and Consequences of Defective Efferocytosis in Atherosclerosis.
    Yurdagul A; Doran AC; Cai B; Fredman G; Tabas IA
    Front Cardiovasc Med; 2017; 4():86. PubMed ID: 29379788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating inflammation-resolving lipid mediators RvD1 and DHA are decreased in patients with acutely symptomatic carotid disease.
    Bazan HA; Lu Y; Jun B; Fang Z; Woods TC; Hong S
    Prostaglandins Leukot Essent Fatty Acids; 2017 Oct; 125():43-47. PubMed ID: 28987721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fine-tuning inflammation-resolution programs: focus on atherosclerosis.
    Fredman G; Sadhu S; Rymut N
    Curr Opin Clin Nutr Metab Care; 2017 Mar; 20(2):117-123. PubMed ID: 27984234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disrupted balance between pro-inflammatory lipid mediators and anti-inflammatory specialized pro-resolving mediators is linked to hyperinflammation in patients with alcoholic hepatitis.
    Li W; Xia Y; Yang J; Sanyal AJ; Shah VH; Chalasani NP; Yu Q
    medRxiv; 2023 Dec; ():. PubMed ID: 38168393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profiling of lipid mediators in atherosclerotic carotid plaques from type 2 diabetic and non-diabetic patients.
    Ménégaut L; Laubriet A; Crespy V; Nguyen M; Petit JM; Tarris G; Pilot T; Varin A; Choubley H; Bergas V; de Barros JP; Thomas C; Steinmetz E; Masson D
    Prostaglandins Leukot Essent Fatty Acids; 2022 Sep; 184():102477. PubMed ID: 35952424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-Inflammatory Benefits of Antibiotics: Tylvalosin Induces Apoptosis of Porcine Neutrophils and Macrophages, Promotes Efferocytosis, and Inhibits Pro-Inflammatory CXCL-8, IL1α, and LTB
    Moges R; De Lamache DD; Sajedy S; Renaux BS; Hollenberg MD; Muench G; Abbott EM; Buret AG
    Front Vet Sci; 2018; 5():57. PubMed ID: 29696149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specialized pro-resolving mediators in cardiovascular diseases.
    Fredman G; Spite M
    Mol Aspects Med; 2017 Dec; 58():65-71. PubMed ID: 28257820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiation-Induced Macrophage Senescence Impairs Resolution Programs and Drives Cardiovascular Inflammation.
    Sadhu S; Decker C; Sansbury BE; Marinello M; Seyfried A; Howard J; Mori M; Hosseini Z; Arunachalam T; Finn AV; Lamar JM; Jourd'heuil D; Guo L; MacNamara KC; Spite M; Fredman G
    J Immunol; 2021 Oct; 207(7):1812-1823. PubMed ID: 34462312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resolvin D1 delivery to lesional macrophages using antioxidative black phosphorus nanosheets for atherosclerosis treatment.
    He Z; Chen W; Hu K; Luo Y; Zeng W; He X; Li T; Ouyang J; Li Y; Xie L; Zhang Y; Xu Q; Yang S; Guo M; Zou W; Li Y; Huang L; Chen L; Zhang X; Saiding Q; Wang R; Zhang MR; Kong N; Xie T; Song X; Tao W
    Nat Nanotechnol; 2024 Jun; ():. PubMed ID: 38898135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resolving neutrophils through genetic deletion of TRAM attenuate atherosclerosis pathogenesis.
    Geng S; Zhang Y; Lu R; Irimia D; Li L
    iScience; 2024 Jun; 27(6):110097. PubMed ID: 38883832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting inflammation and pro-resolving mediators with Anetholea anisita extract to improve scalp condition.
    Duroux R; Baillif V; Havas F; Farge M; Maurin A; Suere T; VanGoethem E; Attia J
    Int J Cosmet Sci; 2022 Dec; 44(6):614-624. PubMed ID: 35979727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resolvin D1 Dampens Pulmonary Inflammation and Promotes Clearance of Nontypeable Haemophilus influenzae.
    Croasdell A; Lacy SH; Thatcher TH; Sime PJ; Phipps RP
    J Immunol; 2016 Mar; 196(6):2742-52. PubMed ID: 26843331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased numbers of regulatory T cells are associated with human atherosclerotic lesion vulnerability and inversely correlate with infiltrated mature dendritic cells.
    Dietel B; Cicha I; Voskens CJ; Verhoeven E; Achenbach S; Garlichs CD
    Atherosclerosis; 2013 Sep; 230(1):92-9. PubMed ID: 23958259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can Inflammation-Resolution Provide Clues to Treat Patients According to Their Plaque Phenotype?
    Fredman G
    Front Pharmacol; 2019; 10():205. PubMed ID: 30899222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer's Disease and Specialized Pro-Resolving Lipid Mediators: Do MaR1, RvD1, and NPD1 Show Promise for Prevention and Treatment?
    Miyazawa K; Fukunaga H; Tatewaki Y; Takano Y; Yamamoto S; Mutoh T; Taki Y
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32806612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a non-growth factor role for GM-CSF in advanced atherosclerosis: promotion of macrophage apoptosis and plaque necrosis through IL-23 signaling.
    Subramanian M; Thorp E; Tabas I
    Circ Res; 2015 Jan; 116(2):e13-24. PubMed ID: 25348165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Shifting the Biosynthesis of Leukotrienes Toward Specialized Pro-Resolving Mediators by the 5-Lipoxygenase-Activating Protein (FLAP) Antagonist BRP-201.
    Kretzer C; Jordan PM; Bilancia R; Rossi A; Gür Maz T; Banoglu E; Schubert US; Werz O
    J Inflamm Res; 2022; 15():911-925. PubMed ID: 35173459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytotoxic and proinflammatory CD8+ T lymphocytes promote development of vulnerable atherosclerotic plaques in apoE-deficient mice.
    Kyaw T; Winship A; Tay C; Kanellakis P; Hosseini H; Cao A; Li P; Tipping P; Bobik A; Toh BH
    Circulation; 2013 Mar; 127(9):1028-39. PubMed ID: 23395974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenchymal Stem Cells Stabilize Atherosclerotic Vulnerable Plaque by Anti-Inflammatory Properties.
    Wang SS; Hu SW; Zhang QH; Xia AX; Jiang ZX; Chen XM
    PLoS One; 2015; 10(8):e0136026. PubMed ID: 26288013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roles of Specialized Pro-Resolving Lipid Mediators in Cerebral Ischemia Reperfusion Injury.
    Yin P; Wei Y; Wang X; Zhu M; Feng J
    Front Neurol; 2018; 9():617. PubMed ID: 30131754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.